24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Oncology
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:10
Israel’s tech layoffs aren't just a crisis, they’re a talent redistribution opportunity
09:11
The algorithm has no passport: Europe's ultimatum to global tech
08:14
Israel can afford a bigger defense budget. Can it afford the civilian trade-off?
07:47
Sergey Brin is pushing Google to go all in on Gemini as AI race intensifies
More stories
Buzz
Most popular
Daily
Weekly
1
Palo Alto’s CEO bought the dip. Five months later, his $10 million bet is worth $26 million
2
OpenAI recruits Wiz's COO to lead its next phase of growth
3
Why Anthropic is willing to pay $6 billion for Decart
4
Anthropic in talks to acquire Israeli AI startup Decart for $6 billion
5
Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling
More news
Oncology
6 stories about Oncology
“Younger people are getting cancer more and more. We have to make kinder medicines.”
14.12.25
|
Zachy Hennessey
As AI hype accelerates, oncology’s real progress is happening quietly, driven by data, regulation, and the slow work of making cancer treatment more precise and sustainable
Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline
15.03.23
|
CTech
The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches
Nucleai raises $33 million for spatial biology drug development platform
22.03.22
|
Meir Orbach
The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
Israel’s Zebra Medical Vision gets its first FDA clearance in oncology
28.07.20
|
James Spiro
The new approval marks the sixth time the medical imaging company has earned FDA clearance
Oncology Company Alpha Tau Raises $29 Million
06.09.18
|
Hezi Sternlicht
Alpha Tau’s cancer treatment technology uses alpha radiation to treat solid tumors with radiation particles that are released inside the tumor, killing the surrounding cells
Israeli Oncology Company Alpha Tau is Raising Funds
22.08.18
|
Hezi Sternlicht
Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars